CUTRQ — Cutera Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Cutera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	182	148	231	252	212
Cost of Revenue
Gross Profit	98.2	75.8	133	140	41.5
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	194	171	222	325	369
Operating Profit	-12.1	-22.8	9.02	-72.6	-156
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-12.3	-23.4	3.38	-80.7	-161
Provision for Income Taxes
Net Income After Taxes	-12.3	-23.9	2.06	-82.3	-163
Net Income Before Extraordinary Items
Net Income	-12.3	-23.9	2.06	-82.3	-163
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-12.3	-23.9	2.06	-82.3	-163
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.876	-1.4	-0.135	-3.2	-8.19